Ezetimibe

Product NDC
70518-2262
11-digit product format
705182262
Labeler code
70518
Product ID
70518-2262_c78eff45-cb1e-f05f-e053-2a95a90a71f0
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ezetimibe
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA209234
Marketing category
ANDA
Marketing start
2019-08-12
Marketing end
0000-00-00
Substance
EZETIMIBE
Active strength
10 mg/1
Pharmacologic classes
Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2262-02023-03-08C16284748780-1f386c64a-3742-0266-e053-dadaa90a7c1a38f438da-3da7-4b5b-bebc-7ee1ef9a167c
70518-2262-02023-01-30C16284748780-1f386c64a-3742-0266-e053-dadaa90a7c1a38f438da-3da7-4b5b-bebc-7ee1ef9a167c

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2262-07051822620090 TABLET in 1 BOTTLE, PLASTIC (70518-2262-0) 90 tablet2019-08-120000-00-00NoNoCurrent